(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib
在IL-6和MYC驱动的人类多发性骨髓瘤小鼠模型中,(18)F-FDG-PET/CT成像可客观评估浆细胞肿瘤的进展以及对蛋白酶体抑制剂伊沙佐米的治疗反应。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2013.61
Duncan, K; Rosean, T R; Tompkins, V S; Olivier, A; Sompallae, R; Zhan, F; Tricot, G; Acevedo, M R; Ponto, L L B; Walsh, S A; Tygrett, L T; Berger, A J; Waldschmidt, T; Morse, H C 3rd; Sunderland, J J; Janz, S
肿瘤
肿瘤免疫
多发性骨髓瘤
骨髓瘤
细胞生物学
MYC
IL-6